Log in
Enquire now
Arrakis Therapeutics

Arrakis Therapeutics

Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.

OverviewStructured DataIssuesContributors

Contents

arrakistx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Healthcare
Healthcare
Biotechnology
Biotechnology
Biology
Biology
RNA-based and RNA-targeted therapeutics
RNA-based and RNA-targeted therapeutics
Medicine
Medicine
‌
Synthetic chemistry
Pharmaceutical industry
Pharmaceutical industry
...
Location
Massachusetts
Massachusetts
Waltham, Massachusetts
Waltham, Massachusetts
United States
United States
B2X
B2B
B2B
Pitchbook URL
pitchbook.com/profiles...170947-63
Number of Employees (Ranges)
51 – 200
Full Address
828 Winter Street, Waltham, MA 02451, US
Investors
Pfizer Venture Investments
Pfizer Venture Investments
Celgene
Celgene
Google Ventures
Google Ventures
HBM Healthcare Investments AG
HBM Healthcare Investments AG
Nextech Invest
Nextech Invest
venBio
venBio
Canaan
Canaan
...
Founded Date
2015
0
Total Funding Amount (USD)
226,000,000
Latest Funding Round Date
April 18, 2019
Competitors
Mineralys Therapeutics
Mineralys Therapeutics
Latest Funding Type
Series B
Series B
Country
United States
United States

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
75,000,000
Public/Private
Private
Wikidata ID
Q30672777

Arrakis Therapeutics is a biopharmaceutical company that is pioneering the discovery of a new class of medicines which targets RNA-targeted small molecules. The company’s platforms, TRYST™ and PEARL-seq™, identify new RNA targets and drug candidates for treating diseases that have not been addressed by today’s medicines.

Arrakis is developing a proprietary pipeline of RNA-targeted small molecules that focuses on neurologic diseases, cancer, and rare genetic diseases.

Arrakis was launched in 2015 by Alan Walts, Ph.D., Russell Petter, Ph.D., Henri Termeer and Raj Parekh, Ph.D. with the vision to develop a proprietary, transformational discovery platform that identifies small-molecule drugs that work on disease-causing RNA.

The company was established with seed funding that was provided by Advent Life Sciences and Henri Termeer. The company puts together scientific leaders in RNA structure, chemistry and biology, together with a management team and the backing of life sciences investors.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Arrakis Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.